Table 1.
Baseline characteristics of adults and children included in the cohort
| Adults | Children | ||||
| N | % | N | % | ||
| Death involving COVID-19 | 118 256 | 0.3 | 21 | <0.01 | |
| COVID-19 hospitalisation | 331 063 | 0.9 | 2930 | 0.1 | |
| ICS | No asthma | 32 530 602 | 92.4 | ||
| No ICS | 565 114 | 1.6 | |||
| Low ICS | 1 451 443 | 4.1 | |||
| Medium ICS | 519 294 | 1.5 | |||
| High ICS | 136 080 | 0.4 | |||
| OCS | No asthma | 32 530 602 | 92.4 | 2 780 630 | 92.8 |
| 0 OCS | 2 072 475 | 5.9 | 197 867 | 6.6 | |
| 1 OCS | 307 486 | 0.9 | 12 944 | 0.4 | |
| 2+ OCS | 291 970 | 0.8 | 5062 | 0.2 | |
| Sex | Female | 18 448 204 | 52.4 | 1 470 953 | 49.1 |
| Male | 16 754 329 | 47.6 | 1 525 550 | 50.9 | |
| Age | Mean | 51.0 | 14.9 | ||
| SD | 19.0 | 1.7 | |||
| Ethnic group | Bangladeshi | 263 624 | 0.7 | 48 062 | 1.6 |
| Black African | 528 677 | 1.5 | 84 971 | 2.8 | |
| Black Caribbean | 378 314 | 1.1 | 26 803 | 0.9 | |
| Chinese | 186 841 | 0.5 | 12 125 | 0.4 | |
| Indian | 939 958 | 2.7 | 86 380 | 2.9 | |
| Mixed | 566 176 | 1.6 | 150 846 | 5.0 | |
| Other | 846 287 | 2.4 | 109 042 | 3.6 | |
| Pakistani | 693 045 | 2.0 | 120 282 | 4.0 | |
| White British | 29 074 171 | 82.6 | 2 245 850 | 74.9 | |
| White other | 1 725 440 | 4.9 | 112 142 | 3.7 | |
| Quintile of Index of Multiple Deprivation | 1 | 6 478 687 | 18.4 | 662 546 | 22.1 |
| 2 | 6 874 247 | 19.5 | 582 881 | 19.5 | |
| 3 | 7 189 513 | 20.4 | 562 070 | 18.8 | |
| 4 | 7 324 784 | 20.8 | 571 206 | 19.1 | |
| 5 | 7 335 302 | 20.8 | 617 800 | 20.6 | |
| Region | North East | 1 767 939 | 5.0 | 138 832 | 4.6 |
| North West | 4 723 007 | 13.4 | 396 101 | 13.2 | |
| Yorkshire and The Humber | 3 593 129 | 10.2 | 304 752 | 10.2 | |
| East Midlands | 3 141 826 | 8.9 | 260 331 | 8.7 | |
| West Midlands | 3 718 733 | 10.6 | 321 909 | 10.7 | |
| East of England | 4 008 795 | 11.4 | 344 332 | 11.5 | |
| London | 4 826 372 | 13.7 | 444 266 | 14.8 | |
| South East | 5 770 900 | 16.4 | 498 722 | 16.6 | |
| South West | 3 651 832 | 10.4 | 287 258 | 9.6 | |
| Hospitalised in previous year (excluding for asthma) | 5 639 375 | 16.0 | 160 463 | 5.4 | |
| Learning disability | None | 34 862 723 | 99.0 | ||
| Other learning disabilities | 332 557 | 0.9 | |||
| Down’s syndrome | 7253 | 0.02 | |||
| Chronic kidney disease | None | 34 697 556 | 98.6 | ||
| CDK 3 | 436 452 | 1.2 | |||
| CDK 4 | 45 653 | 0.1 | |||
| CDK 5 | 22 872 | 0.1 | |||
| Other conditions | Diabetes | 2 558 503 | 7.3 | ||
| COPD | 915 698 | 2.6 | |||
| Stroke | 513 584 | 1.5 | |||
| Atrial fibrillation | 797 049 | 2.3 | |||
| Congestive cardiac failure | 410 692 | 1.2 | |||
| Venous thromboembolism | 9012 | 0.03 | |||
| Peripheral vascular disease | 166 909 | 0.5 | |||
| Dementia | 371 454 | 1.1 | |||
| Parkinson’s disease | 91 259 | 0.3 | |||
| Epilepsy | 192 571 | 0.5 | |||
| Severe mental illness | 3 249 258 | 9.2 | |||
| Osteoporotic fracture | 18 891 | 0.1 | |||
| Rheumatoid arthritis or systemic lupus erythematosus | 239 841 | 0.7 | |||
| Cirrhosis of the liver | 54 585 | 0.2 | |||
CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OCS, oral corticosteroids.